| Latest | F'cast | |
|---|---|---|
| Div Yield | 3.1% | 3.4% |
| Div Cover | 2.4 | 3.0 |
| Op Mrgn | 1.9% | 30.9% |
| ROCE | 13.1% |
| Latest | F'cast | |
|---|---|---|
| P/E | 13.5 | 10.1 |
| PEG | 0.5 | 0.3 |
| Pr/Revenue | 2.1 | 2.2 |
| Pr/Book | 1.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -9.1% | -3.9% |
| PBT | n/a | n/a |
| EPS | 29.1% | 33.7% |
| DPS | n/a | 5.9% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-08 | 245.30 | (67.30) | 7.76p | 7.5 | n/a | -25% | 6.00p | 10.3% |
| 31-Dec-09 | 241.90 | 8.70 | 4.58p | 16.6 | n/a | -41% | 6.00p | 7.9% |
| 31-Dec-10 | 259.80 | (19.20) | 5.70p | 14.7 | 0.6 | +24% | 3.00p | 3.6% |
| 31-Dec-11 | 283.20 | (1.50) | 5.50p | 11.9 | n/a | -4% | 3.00p | 4.6% |
| 31-Dec-12 | 257.40 | (2.50) | 7.10p | 14.4 | 0.5 | +29% | 3.00p | 2.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-13 | 247.38 | 76.56 | 9.50p | 10.1 | 0.3 | +34% | 3.18p | 3.4% |
| 31-Dec-14 | 253.31 | 80.17 | 10.69p | 9.0 | 0.7 | +12% | 3.50p | 3.8% |
Copyright © 2013 FactSet Research Systems Inc. All rights reserved.
| Holding(s) in Company | 22-May-2013 | 16:30 | RNS |
| Director/PDMR Shareholding | 22-May-2013 | 10:16 | RNS |
| Director/PDMR Shareholding | 21-May-2013 | 16:15 | RNS |
| Monday broker round-up UPDATE | 13-May-2013 | ShareCast |
| F&C Asset Management's AuM rises 3.7 per cent | 10-May-2013 | ShareCast |
| Advanced Oncotherapy CEO makes triple purchase | 26-Apr-2013 | ShareCast |
| EU audit rules ‘may add to burden for firms’ | 01-Dec-2011 | The Herald |
| MORE JOBS GO AT F&C | 26-Oct-2011 | Express & Star |
| Activist investor takes over at the helm of F&C | 07-Oct-2011 | The Independent |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 07-May-13 | Buy | Richard Wilson | 98.32p | 128 | £125.85 |
| 07-May-13 | Buy | David Logan | 98.32p | 127 | £124.86 |
| 24-Apr-13 | Buy | Richard Wilson | 95.80p | 351,672 | £336,901.78 |
| Currency | UK Pounds |
| Share Price | 95.75p |
| Change Today | 0.90p |
| % Change | 0.95 % |
| 52 Week High | 110.40 |
| 52 Week Low | 70.00 |
| Volume | 495,839 |
| Shares Issued | 563.60m |
| Market Cap | £539.65m |
| Beta | 0.50 |
| RiskGrade | 146 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 1 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 13 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 03-Apr-13 | 03-Oct-12 |
| Paid | 24-May-13 | 26-Oct-12 |
| Amount | 2.00p | 1.00p |
| Time | Volume / Share Price |
| 16:35 | 89,514 @ 95.75p |
| 16:29 | 2,364 @ 95.55p |
| 16:29 | 687 @ 95.55p |
| 16:29 | 585 @ 95.45p |
| 16:29 | 1,092 @ 95.45p |
| CFO | David Logan |
| CEO | Richard Wilson |
You are here: research